Jeonjin Bio Pharm Decides to Issue 3.5 Billion KRW Convertible Bonds (CB)
[Asia Economy Reporter Eunmo Koo] Jeonjin Bio Pharm announced on the 16th that it has decided to issue the 7th series of unnamed, interest-bearing, unsecured private convertible bonds (CB) worth 3.5 billion KRW to raise operating funds. The shares to be issued upon conversion amount to 702,106 shares, representing 14.64% of the total number of shares. The nominal interest rate and maturity interest rate are 1% and 5%, respectively, and the bond maturity date is June 18, 2023.
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Man in His 50s Arrested for Confining Girlfriend in Car After She Announced Breakup
- Assaulted by Elementary Student During Class... No Protection Due to 'Instructor' Status
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
